Recent 8-K filings for INIS
Highest-materiality recent filing
Radnostix terminates $12.45M DUF6 plant sale to AFR; voluntary capsule recall
- APA terminated mutually on March 11, 2026; AFR could not pay $12.45M balance by March 31, 2026.
- AFR had paid $170K in non-refundable fees; no closing proceeds received by Radnostix.
-
Radnostix extends Series C Preferred maturity to February 28, 2028
Majority of Series C Preferred holders approved extension of maturity date by one year to February 28, 2028.
-
Radnostix terminates $12.45M DUF6 plant sale to AFR; voluntary capsule recall
APA terminated mutually on March 11, 2026; AFR could not pay $12.45M balance by March 31, 2026.
-
International Isotopes changes name to Radnostix; ticker INIS unchanged
Name changed from International Isotopes Inc. to Radnostix, Inc. effective December 23, 2025.
-
International Isotopes CEO Bagerdjian signs 5-year employment agreement; Dr. Fu appointed to board
CEO Shahe Bagerdjian's base salary set at $314K with automatic 5% annual increases through 2030 and up to $250K in milestone raises based on quarterly revenue hitting $3.75M–$25M.
-
CEO Shahe Bagerdjian signs new employment agreement with $314,000 base salary, 5% annual increases, and 37,500,000 RSUs vesting at share price milestones up to $0.30.
-
International Isotopes shareholders approve reverse stock split, re-elect directors
Shareholders approved amendment to certificate of formation for reverse stock split at ratio 1:50 to 1:275, with exact ratio set by Board.
-
International Isotopes extends Series C Preferred maturity to Feb 28, 2027
Majority of Series C Preferred stockholders approved a two-year maturity extension to February 28, 2027.
-
International Isotopes elects four directors, ratifies auditor at 2024 annual meeting
Shareholders elected Robert Atcher, Shahe Bagerdjian, Christopher Grosso, and Steve T. Laflin as directors for one-year terms.
Materiality & sentiment trend
Max materiality 0.70 · Median 0.55 · Most common event other_material